81180 Atxn3 gene detc abnor allele
Also known as: ATXN3 repeat analysis, Spinocerebellar Ataxia 3 testing, Machado-Joseph disease testing
Molecular analysis of the ATXN3 gene to detect abnormal CAG repeat expansions associated with Spinocerebellar Ataxia type 3 (Machado-Joseph disease).
In Plain Language
ataxia gene test; Machado-Joseph disease screening
Clinical Context
Ordered to diagnose Spinocerebellar Ataxia type 3, the most common dominant ataxia, in patients with progressive cerebellar ataxia and family history.
RVU Information
CPT 81180 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81180?
CPT 81180 (Atxn3 gene detc abnor allele) is a Pathology & Lab code. Molecular analysis of the ATXN3 gene to detect abnormal CAG repeat expansions associated with Spinocerebellar Ataxia type 3 (Machado-Joseph disease).
Who uses CPT code 81180?
CPT 81180 is used by Genetics, Neurology, Pathology. Ordered to diagnose Spinocerebellar Ataxia type 3, the most common dominant ataxia, in patients with progressive cerebellar ataxia and family history.
When is CPT 81180 used?
Ordered to diagnose Spinocerebellar Ataxia type 3, the most common dominant ataxia, in patients with progressive cerebellar ataxia and family history.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.